Prognostic implications of the immunophenotype in biphenotypic acute leukemia

Leukemia and Lymphoma

Volumn 49, Issue 4, 2008, Pages 700-709

  Lee, Je Hwan ^a   Min, Yoo Hong ^b   Chung, Chul Won ^c   Kim, Byoung Kook ^d   Yoon, Hwi Joong ^e   Jo, Deog Yeon ^f   Shin, Ho Jin ^g   Bang, Soo Mee ^h   Won, Jong Ho ⁱ   Zang, Dae Young ^j   Kim, Hyeoung Joon ^k   Chi, Hyun Sook ^a   Lee, Kyoo Hyung ^a   Cheong, June Won ^b   Kim, Jin Seok ^b   Kim, Sun Hee ^c   Park, Seonyang ^d   Park, Su Yon ^e   Chung, Joo Seop ^g   Lee, Jae Hoon ^h   Park, Chan Jeoung ^a   more..

^a University of Ulsan College of Medicine   (South Korea)

^b Yonsei University College of Medicine   (South Korea)

^c Sungkyunkwan University School of Medicine   (South Korea)

^d Seoul National University Hospital   (South Korea)

^e Kyung Hee University College of Medicine   (South Korea)

^f Chungnam National University College of Medicine   (South Korea)

^g Pusan National University Hospital   (South Korea)

^h Gachon University College of Medicine   (South Korea)

ⁱ Soonchunhyang University College of Medicine   (South Korea)

^j Hallym University Medical Center   (South Korea)

^k Chonnam National University Hwasun Hospital and Medical School   (South Korea)

more..

Author keywords

Acute leukemia; Biphenotypic; Immunophenotype

Indexed keywords

ANTILEUKEMIC AGENT; ASPARAGINASE; CYCLOPHOSPHAMIDE; CYTARABINE; DAUNORUBICIN; DOXORUBICIN; ETOPOSIDE; IDARUBICIN; IMATINIB; METHOTREXATE; MITOXANTRONE; PREDNISOLONE; RETINOIC ACID; VINCRISTINE;

ACUTE GRANULOCYTIC LEUKEMIA; ACUTE LEUKEMIA; ADOLESCENT; ADULT; AGED; ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION; AUTOLOGOUS HEMATOPOIETIC STEM CELL TRANSPLANTATION; B LYMPHOCYTE; BLOOD ANALYSIS; CANCER INCIDENCE; CANCER REGRESSION; CANCER SURVIVAL; CLINICAL ARTICLE; CONFERENCE PAPER; CONTROLLED STUDY; DISEASE FREE SURVIVAL; DRUG MEGADOSE; DRUG RESPONSE; DRUG TREATMENT FAILURE; FEMALE; HUMAN; HUMAN CELL; IMMUNOPHENOTYPING; MALE; MEDICAL RECORD REVIEW; OVERALL SURVIVAL; PHENOTYPE; PRIORITY JOURNAL; PROGNOSIS; SOUTH KOREA; SURVIVAL RATE; SURVIVAL TIME; T LYMPHOCYTE;

ADOLESCENT; ADULT; AGED; B-LYMPHOCYTES; BIOLOGICAL MARKERS; FEMALE; HUMANS; IMMUNOPHENOTYPING; KOREA; LEUKEMIA, BIPHENOTYPIC, ACUTE; MALE; MIDDLE AGED; MYELOID CELLS; PROGNOSIS; REMISSION INDUCTION; RETROSPECTIVE STUDIES; SURVIVAL ANALYSIS; T-LYMPHOCYTES;

EID: 42049097086     PISSN: 10428194     EISSN: 10292403     Source Type: Journal    
DOI: 10.1080/10428190701843247     Document Type: Conference Paper

References (32)

1. Greaves, M. F. (1986) Differentiation-linked leukemogenesis in lymphocytes. Science, 234, pp. 697-704.
2. Altman, A. J. (1990) Clinical features and biological implications of acute mixed lineage (hybrid) leukemias. Am J Pediatr Hematol Oncol, 12, pp. 123-133.
3. Bene, M. C., Castoldi, G., Knapp, W., Ludwig, W. D., Matutes, E. and Orfao, A. (1995) Proposals for the immunological classification of acute leukemias. European Group for the Immunological Characterization of Leukemias (EGIL). Leukemia, 9, pp. 1783-1786.
4. Carbonell, F., Swansbury, J., Min, T., Matutes, E., Farahat, N. and Buccheri, V. (1996) Cytogenetic findings in acute biphenotypic leukaemia. Leukemia, 10, pp. 1283-1287.
5. Hurwitz, C. A. and Mirro Jr, J. (1990) Mixed-lineage leukemia and asynchronous antigen expression. Hematol Oncol Clin North Am, 4, pp. 767-794.
6. Kantarjian, H. M., Hirsch-Ginsberg, C., Yee, G., Huh, Y., Freireich, E. J. and Stass, S. (1990) Mixed-lineage leukemia revisited: Acute lymphocytic leukemia with myeloperoxidase-positive blasts by electron microscopy. Blood, 76, pp. 808-813.
7. Killick, S., Matutes, E., Powles, R. L., Hamblin, M., Swansbury, J. and Treleaven, J. G. (1999) Outcome of biphenotypic acute leukemia. Haematologica, 84, pp. 699-706.
8. Legrand, O., Perrot, J. Y., Simonin, G., Baudard, M., Cadiou, M. and Blanc, C. (1998) Adult biphenotypic acute leukaemia: An entity with poor prognosis which is related to unfavourable cytogenetics and P-glycoprotein over-expression. Brit J Haematol, 100, pp. 147-155.
9. Matutes, E., Morilla, R., Farahat, N., Carbonell, F., Swansbury, J. and Dyer, M. (1997) Definition of acute biphenotypic leukemia. Haematologica, 82, pp. 64-66.
10. Mirro, J., Zipf, T. F., Pui, C. H., Kitchingman, G., Williams, D. and Melvin, S. (1985) Acute mixed lineage leukemia: Clinicopathologic correlations and prognostic significance. Blood, 66, pp. 1115-1123.
11. Owaidah, T. M., Beihany, A Al, Iqbal, M. A., Elkum, N. and Roberts, G. T. (2006) Cytogenetics, molecular and ultrastructural characteristics of biphenotypic acute leukemia identified by the EGIL scoring system. Leukemia, 20, pp. 620-626.
12. Sulak, L. E., Clare, C. N., Morale, B. A., Hansen, K. L. and Montiel, M. M. (1990) Biphenotypic acute leukemia in adults. Am J Clin Pathol, 94, pp. 54-58.
13. Greaves, M. F., Chan, L. C., Furley, A. J., Watt, S. M. and Molgaard, H. V. (1986) Lineage promiscuity in hemopoietic differentiation and leukemia. Blood, 67, pp. 1-11.
14. Smith, L. J., Curtis, J. E., Messner, H. A., Senn, J. S., Furthmayr, H. and McCulloch, E. A. (1983) Lineage infidelity in acute leukemia. Blood, 61, pp. 1138-1145.
15. The value of c-kit in the diagnosis of biphenotypic acute leukemia (1998) EGIL (European Group for the Immunological Classification of Leukaemias). Leukemia, 12, p. 2038.
16. Hanson, C. A., Abaza, M., Sheldon, S., Ross, C. W., Schnitzer, B. and Stoolman, L. M. (1993) Acute biphenotypic leukaemia: Immunophenotypic and cytogenetic analysis. Brit J Haematol, 84, pp. 49-60.
17. Thalhammer-Scherrer, R., Mitterbauer, G., Simonitsch, I., Jaeger, U., Lechner, K. and Schneider, B. (2002) The immunophenotype of 325 adult acute leukemias: Relationship to morphologic and molecular classification and proposal for a minimal screening program highly predictive for lineage discrimination. Am J Clin Pathol, 117, pp. 380-389.
18. Cross, A. H., Goorha, R. M., Nuss, R., Behm, F. G., Murphy, S. B. and Kalwinsky, D. K. (1988) Acute myeloid leukemia with T-lymphoid features: a distinct biologic and clinical entity. Blood, 72, pp. 579-587.
19. Ball, E. D., Davis, R. B., Griffin, J. D., Mayer, R. J., Davey, F. R. and Arthur, D. C. (1991) Prognostic value of lymphocyte surface markers in acute myeloid leukemia. Blood, 77, pp. 2242-2250.
20. Ferrara, F. and Vecchio, L Del (1992) Clinical relevance of acute mixed-lineage leukemia. Blood, 79, pp. 2799-2800.
21. Kita, K., Miwa, H., Nakase, K., Kawakami, K., Kobayashi, T. and Shirakawa, S. (1993) Clinical importance of CD7 expression in acute myelocytic leukemia. The Japan Cooperative Group of Leukemia/Lymphoma. Blood, 81, pp. 2399-2405.
22. Kornblau, S. M., Thall, P., Huh, Y. O., Estey, E. and Andreeff, M. (1995) Analysis of CD7 expression in acute myelogenous leukemia: martingale residual plots combined with 'optimal' cutpoint analysis reveals absence of prognostic significance. Leukemia, 9, pp. 1735-1741.
23. Saxena, A., Sheridan, D. P., Card, R. T., McPeek, A. M., Mewdell, C. C. and Skinnider, L. F. (1998) Biologic and clinical significance of CD7 expression in acute myeloid leukemia. Am J Hematol, 58, pp. 278-284.
24. Yumura-Yagi, K., Hara, J., Kurahashi, H., Okamura, J., Koizumi, S. and Toyoda, Y. (1991) Clinical significance of CD7-positive stem cell leukemia. A distinct subtype of mixed lineage leukemia. Cancer, 68, pp. 2273-2280.
25. Cheson, B. D., Bennett, J. M., Kopecky, K. J., Buchner, T., Willman, C. L. and Estey, E. H. (2003) Revised recommendations of the International Working Group for diagnosis, standardization of response criteria, treatment outcomes, and reporting standards for therapeutic trials in acute myeloid leukemia. J Clin Oncol, 21, pp. 4642-4649.
26. Brunning, R. D., Matutes, E., Borowitz, M., Flandrin, G., Head, D. and Vardiman, J. (2001) Acute leukaemias of ambiguous lineage. WHO Tumours of Haematopoietic and Lymphoid Tissues, pp. 106-107. IARC, Lyon
27. Tien, H. F. and Wang, C. H. (1998) CD7 positive hematopoietic progenitors and acute myeloid leukemia and other minimally differentiated leukemia. Leuk Lymphoma, 31, pp. 93-98.
28. Bain, B. J., Barnett, D., Linch, D., Matutes, E. and Reilly, J. T. (2002) Revised guideline on immunophenotyping in acute leukaemias and chronic lymphoproliferative disorders. Clin Lab Haematol, 24, pp. 1-13.
29. Lee, K. H., Lee, J. H., Choi, S. J., Lee, J. H., Seol, M. and Lee, Y. S. (2005) Clinical effect of imatinib added to intensive combination chemotherapy for newly diagnosed Philadelphia chromosome-positive acute lymphoblastic leukemia. Leukemia, 19, pp. 1509-1516.
30. Faderl, S., Thomas, D. A., O'Brien, S., Garcia-Manero, G., Kantarjian, H. M. and Giles, F. J. (2003) Experience with alemtuzumab plus rituximab in patients with relapsed and refractory lymphoid malignancies. Blood, 101, pp. 3413-3415.
31. Laporte, J. P., Isnard, F., Garderet, L., Fouillard, L. and Gorin, N. C. (2004) Remission of adult acute lymphocytic leukaemia with alemtuzumab. Leukemia, 18, pp. 1557-1558.
32. Tibes, R., Keating, M. J., Ferrajoli, A., Wierda, W., Ravandi, F. and Garcia-Manero, G. (2006) Activity of alemtuzumab in patients with CD52-positive acute leukemia. Cancer, 106, pp. 2645-2651.